Graduate Medical Education - Resident Programs | Medical Students

RESEARCH PROJECTS: continued

"Amino-Aqueous (Intravenous Amiodarone) in the Medical Management of Incessant Life-Threatening Ventricular Tachycardia": Primary Investigator, Botsford General Hospital: R. Stomel, D.O.

Nova MR Study - Metabolic Response Pacemaker Study: Intermedics Corporation; Principal Investigator: R. Stomel, D.O.

Circadia DDD Metabolic Response Pacemaker: Intermedics Corporation; Principal Investigator: R. Stomel, D.O.

Irdium-Oxide (IROX) Pacemaker Lead Study: Intermedics Corporation: Principal Investigator: R. Stomel, D.O.

Polyethylene Glycol (PEG) Iridium-Oxide Pacemaker Lead Study: Intermedics Corporation; Principal Investigator: R. Stomel, D.O.

National Registry of Myocardial Infarction: Genentech, Inc.; Primary Investigator: B. Lewis, D.O. Secondary Investigator: R. Stomel, D.O.

"GUSTO" Trial (Global Utilization of Streptokinase and t-Pa for occluded coronary arteries): Principal Investigator (michigan), Botsford General Hospital: R. Stomel, D.O.

"HERO-1" Study (Hirulog and Streptokinase in Treatment of Acute myocardial infarction): Principal Investigator, Botsford General Hospital: R. Stomel, D.O.

Trial to Evaluate the effect of digitalis on mortality in congestive heart failure, digitalis investigation group (DIG), Sponsor, U.S. National Heart, Lung, and Blood Institute (NHLBL); Principal Investigator: B. Lewis, D.O., Secondary investigator: R. Stomel, D.O.

Nebivolol Beta blocker Trial - congestive heart failure study: University of Michigan: Principal Investigator: J. Nicklas, M.D.
Co-Investigator: R. Stomel, D.O.

"Signal-Averaged ECG in congestive heart failure patients" Substudy (Nebivolol).

Objectives and Goals

Method of selection of fellowship candidates

Description of Training Sites

Sample Programs

Research Projects